Suchergebnisse - "Touzeau, Cyrille"

PubPharm (231)

41

T-cell-redirecting bispecific antibodies in multiple myeloma : a revolution?

enthalten in: Blood | 2022

von Moreau, P. | Touzeau, C.

42

Complications of Autologous Stem Cell Transplantation in Multiple Myeloma : Results from the CALM Study

enthalten in: Journal of clinical medicine | 2022

von Waszczuk-Gajda, A. | Penack, O. | Sbianchi, G. | +37

43

Elotuzumab : no benefit for older patients with newly diagnosed multiple myeloma

enthalten in: The Lancet. Haematology | 2022

von Touzeau, C.

CommentOn: Lancet Haematol. 2022 Jun;9(6):e403-e414. - PMID 35550060

44

Anti-SARS-CoV-2 vaccines in recipient and/or donor before allotransplant

enthalten in: EJHaem | 2022

von Jullien, M. | Coste-Burel, M. | Clemenceau, B. | +13

45

Extensive myelitis with eosinophilic meningitis after Chimeric antigen receptor T cells therapy

enthalten in: EJHaem | 2022

von Le Calvez, B. | Eveillard, M. | Decamps, P. | +7

46

B Cell Aplasia Is the Most Powerful Predictive Marker for Poor Humoral Response after BNT162b2 mRNA SARS-CoV-2 Vaccination in Recipients of Allogeneic Hematopoietic Stem Cell Transplantation

enthalten in: Transplantation and cellular therapy | 2022

von Jullien, M. | Le Bourgeois, A. | Coste-Burel, M. | +17

47

Bortezomib and high-dose melphalan conditioning regimen in frontline multiple myeloma : an IFM randomized phase 3 study

enthalten in: Blood | 2022

von Roussel, M. | Lauwers-Cances, V. | Macro, M. | +56

ErratumIn: Blood. 2023 Mar 9;141(10):1234. - PMID 36893003

48

Trends in autologous stem cell transplantation for newly diagnosed multiple myeloma : Changing demographics and outcomes in European Society for Blood and Marrow Transplantation centres from 1995 to 2019

enthalten in: British journal of haematology | 2022

von Swan, D. | Hayden, P. | Eikema, D. | +22

49

Melflufen for the treatment of multiple myeloma

enthalten in: Expert review of clinical pharmacology | 2022

von Ocio, E. | Nadeem, O. | Schjesvold, F. | +5

50

Daratumumab plus lenalidomide and dexamethasone in transplant-ineligible newly diagnosed multiple myeloma : frailty subgroup analysis of MAIA

enthalten in: Leukemia | 2022

von Facon, T. | Cook, G. | Usmani, S. | +25